Adrenal insufficiency can arise from a primary adrenal disorder, secondary to
adrenocorticotropic hormone deficiency, or by suppression of adrenocorticotropic hormone …

Adrenal insufficiency (AI) is a condition characterized by an absolute or relative deficiency of
adrenal cortisol production. Primary AI (PAI) is rare and is caused by direct adrenal failure …

Rationale: There is a need to minimize oral corticosteroid (OCS) use in patients with asthma
to prevent their costly and burdensome adverse effects. Current guidelines do not provide …

Addison's disease–the traditional term for primary adrenal insufficiency (PAI)–is defined as
the clinical manifestation of chronic glucocorticoid-and/or mineralocorticoid deficiency due to …

Adrenal insufficiency (AI) is a life-threatening condition requiring life-long glucocorticoid
(GC) substitution therapy, as well as stress adaptation to prevent adrenal crises. The number …

The effects of long-term replacement therapy of adrenal insufficiency (AI) are still a matter of
controversy. In fact, the established glucocorticoid replacement regimens do not completely …

Adrenal insufficiency (AI), first described by Thomas Addison in 1855, is characterised by
inadequate hormonal production by the adrenal gland, which could either be primary, due to …

Introduction: Despite major advances in kidney transplant, glucocorticoids (GCs) or steroids
remain one of the mainstay treatments. They possess adverse events (AEs) that are related …

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global health crisis affecting …

Context Glucocorticoid (GC) replacement therapy in patients with adrenal insufficiency (AI) is
life saving. After over 50 years of conventional GC treatment, novel formulations are now …